Peter Baulk

Title: Innovations of Peter Baulk in Targeting Angiogenic Endothelial Cells

Introduction

Peter Baulk is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biomedical research, particularly in the development of cationic lipid compositions. With a total of 2 patents, his work focuses on innovative methods to target angiogenic endothelial cells.

Latest Patents

Baulk's latest patents include groundbreaking technologies that utilize lipid/DNA complexes or cationic liposomes. These compositions are designed to selectively target angiogenic endothelial cells, which play a crucial role in various physiological and pathological processes. By administering cationic liposomes containing a detectable label, researchers can precisely locate sites of angiogenesis. The complexes may also comprise nucleotide constructs with promoters that are selectively activated in the environment of angiogenic endothelial cells, allowing for targeted therapeutic interventions.

Career Highlights

Peter Baulk is affiliated with the University of California, where he continues to advance his research. His innovative approaches have garnered attention in the scientific community, contributing to the understanding of angiogenesis and its implications in health and disease.

Collaborations

Some of Baulk's notable coworkers include Donald M McDonald and John McLean. Their collaborative efforts have further enhanced the research and development of targeted therapies in the field.

Conclusion

Peter Baulk's work exemplifies the intersection of innovation and biomedical research. His patents and ongoing research efforts are paving the way for new therapeutic strategies targeting angiogenic endothelial cells.